Strand Therapeutics Funding: $153M Raised, Series B (2024)
Strand Therapeutics is based in Boston, Massachusetts. It has raised $153M in total funding. Latest round: Series B.
Strand Therapeutics funding overview
Strand Therapeutics is based in Boston, Massachusetts. Strand Therapeutics has raised $153M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2024. The round record for Strand Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Forbes, Endpoints News, FierceBiotech, Boston Business Journal. 4 distinct backers are named across the disclosed rounds.
Strand Therapeutics at a glance
Total raised
$153M
Latest round
Series B
Latest round date
January 2024
Headquarters
Boston, Massachusetts
Notable investors
Forbes, Endpoints News, FierceBiotech, Boston Business Journal
Frequently asked about Strand Therapeutics funding
How much has Strand Therapeutics raised?
Strand Therapeutics has raised $153M in total disclosed funding across the rounds on record.
Who has invested in Strand Therapeutics?
Forbes, Endpoints News, FierceBiotech, Boston Business Journal are named among the investors backing Strand Therapeutics.
What was the latest Strand Therapeutics funding round?
The most recent disclosed round is a Series B, announced in January 2024.
Where is Strand Therapeutics based?
Strand Therapeutics is based in Boston, Massachusetts.
When did Strand Therapeutics last raise?
The last disclosed Strand Therapeutics round closed in January 2024 at Series B.
Round data for Strand Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Boston and backer lists below.
